This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Intellectual Property

Feb. 6, 2023

UC neurologist wins more than $5M from startup

According to the trial counsel, Dr. Jim Brewer was not paid stock options he was promised by the Impact executives, for his contributions to their research for a drug, fedratinib, that was on clinical hold with the Food and Drug Administration.

A trial team Ellis, George, Cipollone, O’Brien, Annaguey LLP in Los Angeles secured a jury verdict for the head of neurology at UC San Diego for more than $5 million, including punitive damages, in a dispute with a startup drug company, Impact Biomedicines, and Bristol Myers Squibb Co.

According to the trial counsel for Dr. Jim Brewer — Christopher W. Arledge and Courtney L. Mitchell — he was not paid stock options he was promised by the I...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up